![Kevin Tan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kevin Tan
Directeur Financier/CFO chez
SOLID BIOSCIENCES INC.
Fortune : 993 226 $ au 30/06/2026
Profil
Kevin Tan is currently Chief Financial Officer & Treasurer at Solid Biosciences, Inc. since 2023.
Former roles include Treasurer at Sarepta Therapeutics, Inc. from 2020 to 2021, Chief Financial & Accounting Officer at Selecta Biosciences, Inc. from 2021 to 2022, and Senior Portfolio Manager at CPP Investments Ltd. Education includes undergraduate studies at Queen's University, graduate studies at Princeton University, and an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/02/2026 | 99 422 ( 0,1% ) | 993 226 $ | 30/06/2026 |
Postes actifs de Kevin Tan
| Sociétés | Poste | Début |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur Financier/CFO | 09/01/2023 |
Anciens postes connus de Kevin Tan
| Sociétés | Poste | Fin |
|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Directeur Financier/CFO | 28/11/2022 |
| SAREPTA THERAPEUTICS, INC. | Treasurer | 01/09/2021 |
CPP Investments Ltd.
 CPP Investments Ltd. Investment ManagersFinance Provides investment management services | Corporate Officer/Principal | - |
Formation de Kevin Tan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Sarepta Therapeutics, Inc.
 Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Develops targeted immunotherapies and vaccines to treat and prevent diseases | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
 Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
CPP Investments Ltd.
CPP Investments Ltd. Investment ManagersFinance Provides investment management services | Finance |
Choisissez Zonebourse 
